Meta AnalysisID 4333

膳食钠与非酒精性脂肪性肝病:一项系统评价

CRD42023390447

The objective of this review is to compile and critically analyze research in humans and animals that verified the influence of different patterns of sodium consumption on NAFLD markers.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
4333
Evidence Id
12891
Core Evidence Id
12891
Source Meta Analysis Id
4300
Herb2 Meta Analysis Id
HBMA004300
Crd Id
CRD42023390447
Title
Dietary Sodium and nonalcoholic fatty liver disease: a systematic review
Review Question
The objective of this review is to compile and critically analyze research in humans and animals that verified the influence of different patterns of sodium consumption on NAFLD markers.
Study Type Included
There are no restriction on the type of study
Condition Being Studied
Nonalcoholic Fatty Liver Disease
Participant
The studies could be in humans (without the restriction of the population studied) or experimental animals.
Animal
Human Disease Modelled
Intervention
The studies should compare the prevalence/incidence of NAFLD, or, if intervention, the alteration of steatosis or fibrosis markers in the liver tissue according to sodium intake. In humans, sodium consumption should have been assessed bya food frequency questionnaire, 24-hour recall, 24-hour urine collection, or urine collection < 24 hours. NAFLD should have been assessed by biopsy, FIBROSCAN, ultrasound, or validated formulas. Those studies that reported only the dietary pattern of people with NAFLD without correction for con-founding factors, even though sodium intake was compared between cases and control, were not selected.
Comparator Control
People/animals fed normal or low-sodium intake
Main Outcome
The prevalence/incidence of NAFLD, or, if intervention, the alteration of steatosis and/or fibrosis markers in the liver according to sodium intake in humans. Steatosis markers in experimental animals. Measures of effect Odds ratio, Hazard ratio
Outcome Measure
Additional Outcome
Not applicable
Study Method
Narrative synthesis, Systematic review
Keyword
Animals; Diet; Humans; Non-alcoholic Fatty Liver Disease; Sodium; Sodium Chloride, Dietary; Sodium, Dietary
Contact
Guilherme Ferreira [email protected]
Organisational Affiliation
Laboratorio de Lípides (LIM 10) do Hospital das Clínicas (HCFMUSP) da Faculdade de Medicina da Universidade de Sao Paulo
Funding Source
Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP, (#2016/15603-0 to MP), and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES; 001, to GSF), and Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq (to MP), Brazil. Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> FAPESP, (#2016/15603-0 to MP); CAPES (# 001 to GSF)
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English, Portuguese-Brazil
Country
Brazil
Review Stage
Review Ongoing
First Submission Date
2023-01-09
Registration Date
2023-01-20
Anticipated Start Date
2021-06-01
Anticipated Completion Date
2023-02-07
Title Cn
膳食钠与非酒精性脂肪性肝病:一项系统评价
Title En
Dietary Sodium and nonalcoholic fatty liver disease: a systematic review
Bilingual Status
complete